| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |